Localized-statistical quantification of human serum proteome associated with type 2 diabetes

Area of Science:

• Proteomics
• Biomarker Discovery
• Systems Biology

Background:

• Proteomics advances enable serum biomarker discovery for diabetes progression.
• Understanding diabetes molecular mechanisms is crucial.

Purpose of the Study:

• To identify serum protein biomarkers for type 2 diabetes.
• To analyze proteomic data using a novel computational strategy.
• To investigate pathway associations with type 2 diabetes.

Main Methods:

• Proteomic analysis of human serum from diabetic and non-diabetic cohorts.
• Development and application of the localized statistics of protein abundance distribution (LSPAD) method.
• Pathway-associated analysis to identify biased biological pathways.

Main Results:

• Identified 68 significantly over-represented proteins in diabetic serum (p<0.01).
• Uncovered significant over-representation of the complement system in type 2 diabetes.
• Observed and validated over-representation of ficolin-3 in type 2 diabetic patients' serum (p=0.012).

Conclusions:

• The LSPAD approach is effective for analyzing complex proteomic data, like plasma proteomes.
• Disclosed comprehensive protein distributions associated with diabetes.
• Revealed the involvement of ficolin-related complement activation in diabetes.